Litcius/Paper detail

Predicting the risk of subsequent progression in patients with systemic sclerosis-associated interstitial lung disease with progression: a multicentre observational cohort study

Anna‐Maria Hoffmann‐Vold, L. Petelytska, Håvard Fretheim, Trond Mogens Aaløkken, Mike Oliver Becker, H. J. Bjørkekjær, Cathrine Brunborg, Cosimo Bruni, Christian F. Clarenbach, Phuong Phuong Diep, Rucsandra Dobrota, Michael T. Durheim, Muriel Elhaï, Thomas Frauenfelder, Suiyuan Huang, Suzana Jordan, Emily Langballe, Øyvind Midtvedt, Carina Mihai, Erica Mulcaire-Jones, Janelle Vu Pugashetti, Marco Sprecher, Justin Oldham, Øyvind Molberg, Dinesh Khanna, Oliver Distler

2025The Lancet Rheumatology15 citationsDOI

Topics & Concepts

MedicineObservational studyCohortCohort studyInterstitial lung diseaseDiseaseInternal medicineMultiple sclerosisOncologyLungImmunologySystemic Sclerosis and Related DiseasesInterstitial Lung Diseases and Idiopathic Pulmonary FibrosisInflammatory Myopathies and Dermatomyositis
Predicting the risk of subsequent progression in patients with systemic sclerosis-associated interstitial lung disease with progression: a multicentre observational cohort study | Litcius